ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 31 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $17,000 | -19.0% | 89,363 | 0.0% | 0.00% | – |
Q1 2022 | $21,000 | -60.4% | 89,363 | 0.0% | 0.00% | – |
Q4 2021 | $53,000 | -34.6% | 89,363 | 0.0% | 0.00% | – |
Q3 2021 | $81,000 | -4.7% | 89,363 | +36.9% | 0.00% | – |
Q2 2021 | $85,000 | -6.6% | 65,299 | 0.0% | 0.00% | – |
Q1 2021 | $91,000 | +11.0% | 65,299 | +1.4% | 0.00% | – |
Q4 2020 | $82,000 | +90.7% | 64,429 | +123.7% | 0.00% | – |
Q3 2020 | $43,000 | +38.7% | 28,803 | +47.4% | 0.00% | – |
Q2 2020 | $31,000 | +55.0% | 19,545 | -5.2% | 0.00% | – |
Q1 2020 | $20,000 | -64.3% | 20,609 | 0.0% | 0.00% | – |
Q4 2019 | $56,000 | -30.9% | 20,609 | 0.0% | 0.00% | – |
Q3 2019 | $81,000 | -82.4% | 20,609 | -81.8% | 0.00% | – |
Q2 2019 | $460,000 | -45.8% | 112,945 | -6.5% | 0.00% | – |
Q1 2019 | $848,000 | +28.5% | 120,754 | -0.3% | 0.00% | – |
Q4 2018 | $660,000 | -49.3% | 121,096 | -0.2% | 0.00% | – |
Q3 2018 | $1,302,000 | -12.3% | 121,292 | +6.4% | 0.00% | – |
Q2 2018 | $1,485,000 | +129.2% | 113,981 | +94.0% | 0.00% | – |
Q1 2018 | $648,000 | +9.6% | 58,743 | 0.0% | 0.00% | – |
Q4 2017 | $591,000 | – | 58,743 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
Perceptive Advisors | 132,300 | $929,000 | 0.03% |
Fosun International Ltd | 29,877 | $209,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |